Tonya Brunetti
Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| CD8-Positive T-Lymphocytes | 5 | 2026 | 931 | 0.590 |
Why?
| | Drosophila | 2 | 2015 | 168 | 0.470 |
Why?
| | Drosophila Proteins | 2 | 2015 | 207 | 0.460 |
Why?
| | Myogenic Regulatory Factors | 1 | 2015 | 45 | 0.440 |
Why?
| | Myoblasts | 1 | 2015 | 84 | 0.420 |
Why?
| | Transcriptional Activation | 1 | 2015 | 369 | 0.380 |
Why?
| | Natural Killer T-Cells | 2 | 2022 | 71 | 0.330 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2026 | 1150 | 0.300 |
Why?
| | Mitochondria | 3 | 2025 | 997 | 0.290 |
Why?
| | Membrane Proteins | 1 | 2015 | 1130 | 0.280 |
Why?
| | Immunity, Innate | 2 | 2024 | 844 | 0.240 |
Why?
| | Chemokine CCL3 | 1 | 2026 | 26 | 0.240 |
Why?
| | Mitochondrial Proteins | 2 | 2025 | 263 | 0.230 |
Why?
| | Islets of Langerhans Transplantation | 1 | 2026 | 72 | 0.220 |
Why?
| | Cell Differentiation | 6 | 2026 | 1982 | 0.220 |
Why?
| | Mucosal-Associated Invariant T Cells | 2 | 2022 | 39 | 0.220 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 95 | 0.210 |
Why?
| | Immune Evasion | 1 | 2025 | 64 | 0.210 |
Why?
| | Asthma | 3 | 2021 | 1800 | 0.210 |
Why?
| | Viral Envelope Proteins | 1 | 2025 | 97 | 0.210 |
Why?
| | Vimentin | 1 | 2024 | 47 | 0.210 |
Why?
| | Chikungunya virus | 1 | 2025 | 81 | 0.200 |
Why?
| | Berylliosis | 1 | 2026 | 204 | 0.200 |
Why?
| | Hemin | 1 | 2023 | 4 | 0.200 |
Why?
| | Thymus Gland | 2 | 2024 | 310 | 0.200 |
Why?
| | Single-Cell Analysis | 3 | 2024 | 370 | 0.190 |
Why?
| | Myeloid-Derived Suppressor Cells | 1 | 2024 | 78 | 0.190 |
Why?
| | Immunologic Memory | 1 | 2025 | 369 | 0.180 |
Why?
| | Muscle Fibers, Skeletal | 2 | 2015 | 216 | 0.180 |
Why?
| | Antibodies, Neutralizing | 1 | 2025 | 348 | 0.180 |
Why?
| | Epstein-Barr Virus Infections | 1 | 2023 | 102 | 0.180 |
Why?
| | Quantitative Trait Loci | 2 | 2021 | 388 | 0.180 |
Why?
| | Homeodomain Proteins | 2 | 2018 | 525 | 0.170 |
Why?
| | Streptococcus agalactiae | 1 | 2023 | 118 | 0.170 |
Why?
| | Reactive Oxygen Species | 1 | 2024 | 610 | 0.170 |
Why?
| | Vagina | 1 | 2023 | 202 | 0.170 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2599 | 0.170 |
Why?
| | Immunotherapy | 1 | 2026 | 671 | 0.160 |
Why?
| | Animals | 15 | 2026 | 38107 | 0.160 |
Why?
| | Keratin-15 | 1 | 2020 | 15 | 0.160 |
Why?
| | Antibodies, Viral | 1 | 2025 | 689 | 0.160 |
Why?
| | Genes, p53 | 1 | 2020 | 56 | 0.160 |
Why?
| | Immunotherapy, Adoptive | 1 | 2024 | 356 | 0.160 |
Why?
| | RNA, Long Noncoding | 2 | 2021 | 174 | 0.150 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2020 | 111 | 0.150 |
Why?
| | Mice | 10 | 2026 | 18297 | 0.150 |
Why?
| | Enhancer Elements, Genetic | 2 | 2018 | 190 | 0.150 |
Why?
| | B-Lymphocytes | 1 | 2025 | 887 | 0.150 |
Why?
| | Mental Disorders | 2 | 2018 | 1148 | 0.150 |
Why?
| | Precision Medicine | 1 | 2024 | 462 | 0.150 |
Why?
| | Gene Regulatory Networks | 2 | 2018 | 319 | 0.150 |
Why?
| | Immunoglobulin E | 1 | 2021 | 315 | 0.150 |
Why?
| | POU Domain Factors | 1 | 2018 | 6 | 0.140 |
Why?
| | Genetic Predisposition to Disease | 4 | 2021 | 2488 | 0.140 |
Why?
| | Chromatin Immunoprecipitation | 2 | 2017 | 139 | 0.140 |
Why?
| | Neutrophils | 1 | 2024 | 1133 | 0.140 |
Why?
| | Brain | 3 | 2018 | 2991 | 0.130 |
Why?
| | Melanoma | 1 | 2024 | 765 | 0.130 |
Why?
| | Genomics | 2 | 2024 | 853 | 0.120 |
Why?
| | Skin Neoplasms | 1 | 2024 | 806 | 0.120 |
Why?
| | Whole Genome Sequencing | 1 | 2017 | 183 | 0.120 |
Why?
| | Organoids | 1 | 2018 | 143 | 0.120 |
Why?
| | Leukemia, Myeloid, Acute | 1 | 2023 | 702 | 0.120 |
Why?
| | T-Lymphocytes | 2 | 2024 | 2012 | 0.120 |
Why?
| | Mice, Inbred C57BL | 5 | 2025 | 6034 | 0.120 |
Why?
| | Phenotype | 1 | 2024 | 3206 | 0.120 |
Why?
| | Genotype | 1 | 2021 | 1879 | 0.110 |
Why?
| | Genome-Wide Association Study | 5 | 2021 | 1537 | 0.110 |
Why?
| | MARVEL Domain-Containing Proteins | 1 | 2015 | 1 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2020 | 628 | 0.110 |
Why?
| | Cell Fusion | 1 | 2015 | 47 | 0.110 |
Why?
| | Giant Cells | 1 | 2015 | 21 | 0.110 |
Why?
| | Head and Neck Neoplasms | 1 | 2020 | 563 | 0.110 |
Why?
| | Genome, Human | 1 | 2017 | 431 | 0.110 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 90 | 0.110 |
Why?
| | Muscle Development | 1 | 2015 | 114 | 0.100 |
Why?
| | Animals, Genetically Modified | 1 | 2015 | 248 | 0.100 |
Why?
| | Schizophrenia | 1 | 2018 | 537 | 0.100 |
Why?
| | RNA Interference | 1 | 2015 | 472 | 0.100 |
Why?
| | Humans | 21 | 2026 | 146342 | 0.090 |
Why?
| | Mice, Knockout | 3 | 2026 | 3125 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 633 | 0.090 |
Why?
| | Antineoplastic Agents | 1 | 2024 | 2219 | 0.090 |
Why?
| | DNA-Binding Proteins | 2 | 2020 | 1468 | 0.090 |
Why?
| | Lung | 2 | 2026 | 4122 | 0.090 |
Why?
| | Binding Sites | 1 | 2015 | 1309 | 0.090 |
Why?
| | Cell Nucleus | 1 | 2015 | 584 | 0.090 |
Why?
| | Base Sequence | 1 | 2015 | 2123 | 0.080 |
Why?
| | Adenocarcinoma | 1 | 2018 | 927 | 0.080 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2838 | 0.080 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 944 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2015 | 902 | 0.080 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2026 | 3930 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2021 | 2240 | 0.070 |
Why?
| | Mice, Transgenic | 2 | 2026 | 2134 | 0.070 |
Why?
| | Chemokine CCL4 | 1 | 2026 | 31 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 46 | 0.050 |
Why?
| | Forkhead Box Protein O1 | 1 | 2025 | 36 | 0.050 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 41 | 0.050 |
Why?
| | Cell Proliferation | 2 | 2025 | 2502 | 0.050 |
Why?
| | Rotenone | 1 | 2024 | 21 | 0.050 |
Why?
| | Mice, Inbred NOD | 1 | 2026 | 598 | 0.050 |
Why?
| | Transcription Factors | 1 | 2012 | 1730 | 0.050 |
Why?
| | Cell Respiration | 1 | 2024 | 104 | 0.050 |
Why?
| | Interleukin-10 | 1 | 2026 | 310 | 0.050 |
Why?
| | Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2024 | 39 | 0.050 |
Why?
| | Chikungunya Fever | 1 | 2025 | 82 | 0.050 |
Why?
| | Extracellular Traps | 1 | 2024 | 54 | 0.050 |
Why?
| | DNA-Cytosine Methylases | 1 | 2023 | 3 | 0.050 |
Why?
| | Ovalbumin | 1 | 2024 | 187 | 0.050 |
Why?
| | Melanoma, Experimental | 1 | 2024 | 106 | 0.050 |
Why?
| | Antigens, CD34 | 1 | 2023 | 89 | 0.050 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 1 | 2023 | 43 | 0.050 |
Why?
| | Graft Survival | 1 | 2026 | 523 | 0.050 |
Why?
| | Inflammasomes | 1 | 2024 | 145 | 0.050 |
Why?
| | Heme | 1 | 2023 | 90 | 0.050 |
Why?
| | Epitopes | 1 | 2025 | 479 | 0.050 |
Why?
| | Biological Specimen Banks | 1 | 2024 | 137 | 0.050 |
Why?
| | Phagocytosis | 1 | 2024 | 298 | 0.050 |
Why?
| | Dendritic Cells | 1 | 2026 | 509 | 0.050 |
Why?
| | Herpesvirus 4, Human | 1 | 2023 | 172 | 0.050 |
Why?
| | Americas | 1 | 2021 | 27 | 0.040 |
Why?
| | Spain | 1 | 2021 | 50 | 0.040 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2023 | 340 | 0.040 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2023 | 292 | 0.040 |
Why?
| | Peru | 1 | 2021 | 61 | 0.040 |
Why?
| | Amino Acids | 1 | 2025 | 515 | 0.040 |
Why?
| | Streptococcal Infections | 1 | 2023 | 179 | 0.040 |
Why?
| | Thymocytes | 1 | 2020 | 33 | 0.040 |
Why?
| | HLA-DQ Antigens | 1 | 2021 | 171 | 0.040 |
Why?
| | Peptides | 1 | 2026 | 992 | 0.040 |
Why?
| | Neoplasms, Experimental | 1 | 2020 | 163 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2026 | 852 | 0.040 |
Why?
| | Neoplastic Stem Cells | 1 | 2023 | 403 | 0.040 |
Why?
| | Sulfonamides | 1 | 2023 | 594 | 0.040 |
Why?
| | Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 156 | 0.040 |
Why?
| | Chromosomes, Human, Pair 12 | 1 | 2019 | 22 | 0.040 |
Why?
| | Chromosomes, Human, Pair 17 | 1 | 2019 | 54 | 0.040 |
Why?
| | Postmortem Changes | 1 | 2018 | 15 | 0.040 |
Why?
| | Female | 5 | 2026 | 79499 | 0.040 |
Why?
| | Chromosomes, Human, Pair 8 | 1 | 2019 | 41 | 0.040 |
Why?
| | Receptors, Antigen, T-Cell | 1 | 2022 | 677 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2018 | 110 | 0.030 |
Why?
| | Datasets as Topic | 1 | 2018 | 120 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2020 | 441 | 0.030 |
Why?
| | Open Reading Frames | 1 | 2018 | 130 | 0.030 |
Why?
| | Macrophages | 1 | 2026 | 1532 | 0.030 |
Why?
| | Epigenomics | 1 | 2018 | 124 | 0.030 |
Why?
| | Genomic Library | 1 | 2017 | 15 | 0.030 |
Why?
| | DNA Copy Number Variations | 1 | 2018 | 192 | 0.030 |
Why?
| | Genetic Loci | 1 | 2019 | 273 | 0.030 |
Why?
| | Databases, Genetic | 1 | 2018 | 239 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 2023 | 1432 | 0.030 |
Why?
| | Neural Stem Cells | 1 | 2018 | 167 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2023 | 980 | 0.030 |
Why?
| | Cytokines | 1 | 2024 | 2081 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3545 | 0.030 |
Why?
| | Tumor Microenvironment | 1 | 2020 | 747 | 0.030 |
Why?
| | Disease Progression | 1 | 2023 | 2867 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2026 | 4580 | 0.030 |
Why?
| | Insulin | 1 | 2026 | 2525 | 0.030 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2017 | 539 | 0.030 |
Why?
| | Mutation | 1 | 2025 | 4093 | 0.020 |
Why?
| | Epigenesis, Genetic | 1 | 2018 | 712 | 0.020 |
Why?
| | Gene Expression Profiling | 1 | 2020 | 1792 | 0.020 |
Why?
| | Genetic Variation | 1 | 2018 | 996 | 0.020 |
Why?
| | Colorado | 1 | 2024 | 4595 | 0.020 |
Why?
| | Chromatin | 1 | 2017 | 559 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2020 | 4118 | 0.020 |
Why?
| | Inflammation | 1 | 2024 | 2919 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2814 | 0.020 |
Why?
| | Transcriptome | 1 | 2018 | 1068 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3416 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2018 | 2791 | 0.020 |
Why?
| | Pregnancy | 1 | 2023 | 7230 | 0.020 |
Why?
| | Cohort Studies | 1 | 2021 | 6077 | 0.020 |
Why?
| | Male | 2 | 2025 | 73396 | 0.010 |
Why?
| | Risk Factors | 1 | 2018 | 10921 | 0.010 |
Why?
| | Young Adult | 1 | 2021 | 14330 | 0.010 |
Why?
| | Adolescent | 1 | 2021 | 22557 | 0.010 |
Why?
| | United States | 1 | 2019 | 16136 | 0.010 |
Why?
| | Child | 1 | 2021 | 22693 | 0.010 |
Why?
| | Adult | 1 | 2018 | 41087 | 0.010 |
Why?
|
|
Brunetti's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|